12apocp@gmail.com st. I.K. Akhunbaeva, 92, Bishkek, 720020 0312 54 94 60 рус кыр

Programme

12th General Assembly of the Asia Pacific Organisation for Cancer Prevention

19-21 September 2024

Bishkek, Kyrgyzstan

TENTATIVE AGENDA

19th September 2024, Thursday

Dignitaries: Minister of Health of the Kyrgyz Republic

                     Minister of Education of the Kyrgyz Republic

                     Rector I.K. Akhunbaev KSMA  Prof. Indira Kudaibergenova

                     

 

9.00-10.00 Welcome Addresses

Plenary Session

(Conference Hall)

TIME: 10:00

Moderator: PhD, Professor Alireza Mosavi-Jarrahi

  1. History of the APOCP and Advances in Cancer Control. Nurbek Igissin, President APOCP, Central Asian. (Kazakhstan)

Session I: Cancer Registration, Epidemiology and Control

(Conference Hall №1)

Time: 11:00

Moderators: Doctor of Medical Sciences, Professor Nurbek Igissin, PhD, Professor Malcolm Moore

  1. Cancer Epidemiology and Control in Western and Central Asia. Alireza Mosavi-Jarrahi (Iran)
  2. Development of Population-based Cancer Registration in Kyrgyzstan. Elena Ten (Kyrgyzstan)
  3. National Cancer Registry of Pakistan: First Consolidated Report. Shahid Pervez (Pakistan)
  4. Challenges for Cancer Registration in Central Asia. Anton Barchuk (Russia)
  5. REPCAN: Guideline for Reporting Population-based Cancer Registry Data. Aram Halimi (Iran)

Session II: Cancer Screening and Early Detection

(Conference Hall №1)

Time: 13:30

Moderator: PhD, Professor Alireza Mosavi-Jarrahi

  1. Accelerating Cervical Cancer Elimination Action in China. Youlin Qiao (China).
  2. Analysis of the Effectiveness and Coverage of Breast, Cervical, and Colorectal Cancer Screening Programs in Kazakhstan for the Period 2021-2023: Regional Disparities and Coverage Dynamics. Alfiya Shamsutdinova (Kazakhstan).
  3. Introduction of the HPV vaccine against cervical cancer in Kyrgyzstan. Zhumagulova Gulnara Zhumadylovna (Kyrgyzstan).
  4. Prostate Cancer Incidence Trends in Kazakhstan. Nariman Syzdykov (Kazakhstan).

Session III: Country-Specific Status of Cancer Care

(Conference Hall №1)

Time: 14:10

Moderator: Doctor of Medical Sciences, Professor Bakyt Shainbetov

  1. Cancer Treatment in the Russian Federation (Virtual). Yuriy Komarov (Russia)
  2. Cancer Treatment in Kazakhstan. Tasbolat Adylkhanov (Kazakhstan)
  3. The state of oncology services in the Kyrgyz Republic. Bakyt Shaimbetov (Kyrgyzstan)
  4. Development strategy for the pediatric oncology service of the Republic of Uzbekistan. Djamila Polatava (Uzbekistan).
  5. Trends in Kidney Cancer Stages: Insights from Kazakhstan. Sergey Dyakov (Kazakhstan).
  6. Oncolytic Virotherapy as a smart anti-cancer treatment modality, Dr. Ahmed Majeed Al-Shammari, Iraq
  7. Synergistic effect of pectins and radiation exposure in combination therapy of transplantable tumor. Azamat Kylchykbaev (Kyrgyzstan)

20th September 2024, Friday

Session IV: Recent Advances in Breast Cancer

(Conference Hall №1)

Time: 9:00

Moderator: Professor Cheng-Har Yip

  1. Monitoring the Global Breast Cancer Initiative (Virtual). Sok-King Ong (Brunei)
  2. Challenges of Breast Cancer Control in India: Solutions and Strategies. Maqsood Siddiqui (India).
  3. Challenges of Breast Cancer Control in Kyrgyzstan/Central Asia. Asel Namazbekova (Kyrgyzstan)
  4. Targeting Aerobic Glycolysis through WNT/β-catenin Signalling in Triple-Negative Breast Cancer. Chandra Prakash Prasad (India)
  5. Indirect Economic Burden of Breast Cancer in China, 2021: A Preliminary Measurement Based on A Combination of DALYs And Human Capital Approac. Xinyi Zhou (China)
  6. The link between breast cancer and vitamin D: a pathway-based approach. Saeid Doaei (Iran)
  7. Associations between diet and nutritional supplements and colorectal cancer: A systematic review. Maryam Gholamalizadeh (Iran)

Session V: Recent Advances in Lung Cancer

(Conference Hall №1)

Time: 11:15

Moderator: Professor Akhunbaev Stalbek Mederovich

  1. Advancing Lung Cancer Screening in LMICs: LDCT and beyond. Abhishek Shankar (India)
  2. Lung Cancer Control in Kyrgyzstan and Central Asia. Altynai Momunkuylova (Kyrgyzstan)
  3. A Component-Based Analysis of Lung Cancer Incidence in Kazakhstan. Daulet Yessenbayev (Kazakhstan)
  4. Experience of using fine-needle aspiration biopsy in thyroid cancer diagnostics in Kyrgyzstan. Kim Andrey (Kyrgyzstan)

Session VI: Recent Advances in Gastrointestinal Cancer

(Conference Hall №1)

Time: 13:15

Moderators: Professor Sayakov Umetaly

  1. Surgeon's Strategies for Prevention of Colorectal Cancer. Puneet Dhar (India)
  2. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Colorectal Cancer. Nabiha Missaoui (Tunisia)
  3. Spatial assessment of colon cancer incidence in Kazakhstan. Askhat Axarin (Kazakhstan)
  4. Underlying colorectal cancer physiopathology in response to anti-PD-1 immunotherapy. Pierre Eftekhari (France)
  5. Mini-invasive treatment of cancer esophagus. Bakyt Toktogaziev (Kyrgyzstan)
  6. Liver Cancer Mortality in Kazakhstan: A Retrospective Analysis of the Last Decade. Didar Orazbayev (Kazakhstan)
  7. Cholecystectomy for prevention of gallbladder cancer. Vinay Kapoor (India)
  8. Techniques of effective lymphadenectomy in HPB cancers. Biju Pottakkat (India)
  9. Ways to prevent purulent-inflammatory complications after laparoscopic low rectal resections for cancer. Janek Belekov (Kyrgyzstan)
  10. Cadmium and risk of pancreatic cancer. Mohammad Amin Jahazi (Iran)
  11. Rectal cancer in Kazakhstan: Evaluation of Incidence and Mortality. Zhansaya Telmanova (Kazakhstan)

Session VII: Recent Advances in Gynae Cancer

(Conference Hall №1)

Time: 15:45

Moderator: Dr. Vipin Kharade

  1. Cervical Cancer Control in Kyrgyzstan and Central Asia. Aizada Chynybaeva (Kyrgyzstan)
  2. HPV Vaccines – State of Art. Murat Gultekin (Turkey)
  3. Development of cell-free DNA (cf DNA) based liquid biopsy assay for prognosis of Cervical Cancer. Mayank Singh (India)

Session VIII: Clinical Aspects of Cancer Care

(Conference Hall №1)

Time: 16:25

Moderators:  Dr. Avdhesh Chandra; Dr. Vineet Kumar Kamal

  1. Reconstructive operations after cystectomy for bladder cancer. Sayakov Umetaly (Kyrgyzstan)
  2. Virtual reality in preoperative planning of complex cranial surgery for brain tumors and vascular pathologies. Amol Raheja (India)
  3. Surgical Management of Wilm’ Tumor. Devendra Kumar Yadav (India)
  4. Current Knowledge in pharmaconutrition kethotherapy in Cancer Patient. prof. Saeed Karima. (Iran)
  5. Wood dust and risk of leukemia. Yaser Soleimani/ Mahdi Daraie. (Iran)

21st September 2024, Saturday

Session IX: Clinical Aspects of NCD Control

(Conference Hall №1)

Time: 09:00

Moderator: PhD, Professor Malcolm Moore

  1. Lancet Oncology Commission on Global Cancer Surgery. Cheng-Har Yip (Malaysia)
  2. Lancet Commission on Women and Cancer. Nirmala Bhoo Pathy (Malaysia)
  3. Epidemiology of rheumatology in Kazakhstan. Daulet Yessenbayev (Kazakhstan)
  4. Young Breast Cancer, Unmet needs, Seyed Alireza Javadinia, Iran.
  5. An evaluation of skin and eye diseases associated with solar ultraviolet radiation exposure in central Asia: a systematic review of the literature. Nurkali Assylbek (Kazakhstan)

Session X: Intervention for Cancer Control

(Conference Hall №1)

Time: 11:00

Moderator: PhD, Professor Alireza Mosavi-Jarrahi

  1. Education, Specialist Training and Publication Needs? Malcolm A Moore (UK)
  2. From proposal to publication: manuscript preparation in perspective. Nematullah Shomoossi (Iran)
  3. From Research to Reality: Translating Global Cancer Studies into Practical Solutions for Developing Countries. Alisher Kahharov (Uzbekistan)